Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.480
+0.380 (9.27%)
At close: Nov 20, 2024, 4:00 PM
4.530
+0.050 (1.12%)
Pre-market: Nov 21, 2024, 5:08 AM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $14.39 million as of November 21, 2024. Its market cap has increased by 107.02% in one year.
Market Cap
14.39M
Enterprise Value
4.58M
1-Year Change
107.02%
Ranking
Category
Stock Price
$4.48
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $14.39M, a decrease of -77.61%. That is a compound annual growth rate of -39.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 13.17M | 83.73% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autonomix Medical | 15.39M |
| Cumberland Pharmaceuticals | 15.31M |
| Microbot Medical | 15.18M |
| Minerva Neurosciences | 14.83M |
| Can-Fite BioPharma | 14.75M |
| Psychemedics | 13.79M |
| Vivos Therapeutics | 13.77M |
| Traws Pharma | 13.58M |